CpG-depleted adeno-associated virus vectors evade immune detection.

@article{Faust2013CpGdepletedAV,
  title={CpG-depleted adeno-associated virus vectors evade immune detection.},
  author={Susan M. Faust and Peter Bell and Benjamin J Cutler and Scott N Ashley and Yanqing Zhu and Joseph E. Rabinowitz and James Michael Wilson},
  journal={The Journal of clinical investigation},
  year={2013},
  volume={123 7},
  pages={2994-3001}
}
Due to their efficient transduction potential, adeno-associated virus (AAV) vectors are leading candidates for gene therapy in skeletal muscle diseases. However, immune responses toward the vector or transgene product have been observed in preclinical and clinical studies. TLR9 has been implicated in promoting AAV-directed immune responses, but vectors have not been developed to circumvent this barrier. To assess the requirement of TLR9 in promoting immunity toward AAV-associated antigens… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 4 times. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 35 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 27 references

The genome of self- complementary adeno-associated viral vectors increases Tolllike receptor 9-dependent innate immune responses in the liver

AT Martino
Blood • 2011
View 5 Excerpts
Highly Influenced

Self-complementary AAVs induce more potent transgene product-specific immune responses compared to a single-stranded genome.

Molecular therapy : the journal of the American Society of Gene Therapy • 2012
View 2 Excerpts
Highly Influenced

Gene therapy for alpha1 antitrypsin deficiency

TR Flotte, C. Mueller
Hum Mol Genet • 2011

Similar Papers

Loading similar papers…